CryoPort Inc. (CYRX)
CYRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$16.95
+0.65% on the day
Market cap
$858.5M
Small cap
Revenue · 2025
$176.2M
+12.4% on 2024
Net income · 2025
$78.3M
44.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CYRX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001124524 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $176.2M |
| Net income | $78.3M |
| Operating income | -$36.8M |
| Net margin | 44.4% |
| Operating margin | -20.9% |
| Revenue growth | +12.4% |
| Cash | $250.5M |
| Total assets | $765.0M |
| P/E (computed) | 11.0× |
| P/S (computed) | 4.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2023-12-21 |
| Latest annual report | 10-K | 2026-03-05 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report FORM 8-K | 8-K | 2026-08-06 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.1% |
| 1 month | +2.0% |
| 3 months | +0.9% |
| Year to date | +73.3% |
| 1 year | +77.0% |
| From 52-week high | -8.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SPTX | Seaport Therapeutics Inc. | $16.08 | -6.24% | $860.8M |
| JBIO | Jade Biosciences Inc. | $13.42 | -4.14% | $853.5M |
| ANRO | Alto Neuroscience Inc. | $22.09 | -8.53% | $866.9M |
| ALMS | Alumis Inc. | $6.56 | -7.08% | $849.1M |
| KURA | Kura Oncology Inc. | $9.83 | -5.43% | $874.5M |
| RIGL | Rigel Pharmaceuticals Inc. | $47.14 | -3.42% | $880.6M |
| MLTX | MoonLake Immunotherapeutics | $10.41 | -2.53% | $886.0M |
| AKTS | Aktis Oncology Inc. | $16.64 | -4.04% | $925.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier